Libtayo (cemiplimab)

cemiplimab · Regeneron Pharmaceuticals; Sanofi

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Libtayo (cemiplimab), covering 2025-08-03 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients [Phase 2]